Literature DB >> 20205621

CT imaging of superior semicircular canal dehiscence: added value of reformatted images.

Naim Ceylan1, Selen Bayraktaroglu, Hüdaver Alper, Recep Savaş, Cem Bilgen, Tayfun Kirazli, Ismail Güzelmansur, Sükrü Mehmet Ertürk.   

Abstract

CONCLUSION: Superior semicircular canal dehiscence (SSCD) syndrome may present with various symptoms. CT scans previously interpreted as normal may show SSCD, especially if special reconstructions tailored for superior canal evaluation are added.
OBJECTIVES: The purpose of this study was to investigate prevalence of SSCD, its length and its correlation with symptoms in patients who had previously undergone temporal bone CT examination that was reported normal and to demonstrate the importance of reformatted images in the diagnosis of SSCD.
METHODS: We retrospectively reviewed 108 patients who had undergone temporal bone CT examination for various symptoms and were reported as normal. High-resolution temporal bone CT imaging was performed with 1 mm slice thickness in the transverse plane. Each of the superior semicircular canals was evaluated in the plane of Pöschl and Stenver reformatted images together with axial images.
RESULTS: Ninety-three patients were included in the study. Nineteen patients with semicircular canal dehiscence were detected. The mean age of the study group was 45 years. Radiologic evidence of SSCD occurred in 23 of 186 temporal bones with a radiologic prevalence of 12%. The most common symptoms in dehiscent patients were vertigo, hearing loss and tinnitus. Defect lengths varied between 1 mm and 6.5 mm.

Entities:  

Mesh:

Year:  2010        PMID: 20205621     DOI: 10.3109/00016481003602108

Source DB:  PubMed          Journal:  Acta Otolaryngol        ISSN: 0001-6489            Impact factor:   1.494


  8 in total

1.  Diagnostic performance of reformatted isotropic thin-section helical CT images in the detection of superior semicircular canal dehiscence.

Authors:  Gianvincenzo Sparacia; Alberto Iaia
Journal:  Neuroradiol J       Date:  2017-01-01

2.  Superior semicircular canal dehiscence syndrome as assessed by oVEMP and temporal bone computed tomography imaging.

Authors:  Elsaeid M Thabet; Ahmad Abdelkhalek; Hesham Zaghloul
Journal:  Eur Arch Otorhinolaryngol       Date:  2011-12-23       Impact factor: 2.503

3.  Dehiscence or thinning of bone overlying the superior semicircular canal in idiopathic intracranial hypertension.

Authors:  Güler Berkiten; Defne Gürbüz; Onur Akan; Belgin Tutar; Melis Koşar Tunç; Semih Karaketir; Hasan Sami Bircan; Ertan Berkiten; Hüseyin Sarı; Yavuz Atar; Yavuz Uyar
Journal:  Eur Arch Otorhinolaryngol       Date:  2021-08-23       Impact factor: 2.503

4.  Auditory profile and high resolution CT scan in autism spectrum disorders children with auditory hypersensitivity.

Authors:  Elsaeid M Thabet; Hesham S Zaghloul
Journal:  Eur Arch Otorhinolaryngol       Date:  2013-04-12       Impact factor: 2.503

5.  Superior canal dehiscence syndrome: clinical manifestations and radiologic correlations.

Authors:  Issam Saliba; Anastasios Maniakas; Lina Zahra Benamira; Jade Nehme; Mélanie Benoit; Véronique Montreuil-Jacques
Journal:  Eur Arch Otorhinolaryngol       Date:  2013-10-26       Impact factor: 2.503

6.  Prevalence of radiographic semicircular canal dehiscence in very young children: an evaluation using high-resolution computed tomography of the temporal bones.

Authors:  Mari Hagiwara; Jamil A Shaikh; Yixin Fang; Girish Fatterpekar; Pamela C Roehm
Journal:  Pediatr Radiol       Date:  2012-09-07

7.  Radiographic features of superior semicircular canal dehiscence in the setting of chronic ear disease.

Authors:  Brian C Gartrell; Lindell R Gentry; Tabassum A Kennedy; Samuel P Gubbels
Journal:  Otol Neurotol       Date:  2014-01       Impact factor: 2.311

8.  New classification of superior semicircular canal dehiscence in HRCT.

Authors:  Stephan Waldeck; Heinrich Lanfermann; Christian von Falck; Matthias F Froelich; René Chapot; Marc Brockmann; Daniel Overhoff
Journal:  PLoS One       Date:  2022-01-20       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.